4-hydroxyphenylacetic acid
CAS No. 156-38-7
4-hydroxyphenylacetic acid( —— )
Catalog No. M18084 CAS No. 156-38-7
4-Hydroxybenzeneacetate acid is considered to be slightly soluble (in water) and acidic. 4-Hydroxybenzeneacetate acid can be synthesized from acetic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 200MG | 52 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-hydroxyphenylacetic acid
-
NoteResearch use only, not for human use.
-
Brief Description4-Hydroxybenzeneacetate acid is considered to be slightly soluble (in water) and acidic. 4-Hydroxybenzeneacetate acid can be synthesized from acetic acid.
-
Description4-Hydroxybenzeneacetate acid is considered to be slightly soluble (in water) and acidic. 4-Hydroxybenzeneacetate acid can be synthesized from acetic acid. It can be found throughout numerous foods such as Olives, Cocoa beans, Oats, and Mushrooms. 4-Hydroxybenzeneacetate acid can be found throughout all human tissues and in all biofluids. Within a cell, 4-Hydroxybenzeneacetate acid is primarily located in the cytoplasm and in the extracellular space.(In Vivo):4-Hydroxyphenylacetic acid (6, 12, or 25 mg/kg) increases Nrf2 translocation to the nucleus and enhances the activity of phase II and antioxidant enzymes. The protein levels of nuclear Nrf2 are increased by 170% and 230% in pre-treated 12 and 25 mg/kg 4-Hydroxyphenylacetic acid groups, respectively, compared with the control group.The 4-Hydroxyphenylacetic acid pretreatment at a final dose of 25 mg/kg markedly and selectively up-regulated the target genes of phase II enzymes and resulted in higher up-regulation than that of the control group by 270%, 400%, and 500% or UGT1A1, UGT1A9, and SULT2A1, respectively. 4-Hydroxyphenylacetic acid also suppresses the expression of CYP2E1.
-
In Vitro——
-
In Vivo4-Hydroxyphenylacetic acid (6, 12, or 25 mg/kg) increases Nrf2 translocation to the nucleus and enhances the activity of phase II and antioxidant enzymes. The protein levels of nuclear Nrf2 are increased by 170% and 230% in pre-treated 12 and 25 mg/kg 4-Hydroxyphenylacetic acid groups, respectively, compared with the control group.The 4-Hydroxyphenylacetic acid pretreatment at a final dose of 25 mg/kg markedly and selectively up-regulated the target genes of phase II enzymes and resulted in higher up-regulation than that of the control group by 270%, 400%, and 500% or UGT1A1, UGT1A9, and SULT2A1, respectively. 4-Hydroxyphenylacetic acid also suppresses the expression of CYP2E1.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number156-38-7
-
Formula Weight152.15
-
Molecular FormulaC8H8O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 657.25 mM
-
SMILESOC(=O)Cc1ccc(cc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Egg Laying Hormone, ...
Egg-laying hormone (ELH) is a neuropeptide synthesized by the bag cell neurons, Egg-laying hormone (ELH) induces egg laying and its correlated behavior in Aplysia californica. Egg-laying hormone (ELH) has been purified to homogeneity and Egg-laying hormone (ELH)'s primary structure has been determined. Egg-laying hormone (ELH) have 36 amino acid residues with a Mr of 4385 and a calculated isoelectric point of 9.7. Egg Laying Hormone of Aplysia induces a voltage-dependent slow inward current carried by Na+ in an identified motoneuron.
-
Tocofersolan
Tocofersolan is a polyethylene glycol derivative of α-tocopherol and synthetic water-soluble version of Tocopherol. Tocofersolan is an oral treatment of vitamin E deficiency due to digestive malabsorption in pediatric patients with congenital chronic cholestasis or hereditary chronic cholestasis.
-
ProTx III
Potent Nav1.7 blocker (IC50 = 2.5 nM). Also inhibits Nav1.1, Nav1.2, Nav1.3 and Nav1.6 in the nanomolar range. Exhibits no effects on Cav channels or nAChR at 5 μM. Demonstrates analgesic activity in vivo; antagonizes effects of scorpion-venom toxin OD1 at Nav1.7.
Cart
sales@molnova.com